Velocity Clinical Research Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Velocity Clinical Research's estimated annual revenue is currently $71.8M per year.(i)
  • Velocity Clinical Research's estimated revenue per employee is $201,000

Employee Data

  • Velocity Clinical Research has 357 Employees.(i)
  • Velocity Clinical Research grew their employee count by 35% last year.

Velocity Clinical Research's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
Technical Product OwnerReveal Email/Phone
3
Chief People Officer, Global Human ResourcesReveal Email/Phone
4
Chief Operations OfficerReveal Email/Phone
5
Chief Medical Officer/InvestigatorReveal Email/Phone
6
Chief Commercial OfficerReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Chief Technology OfficerReveal Email/Phone
9
Chief Strategic Delivery OfficerReveal Email/Phone
10
Chief Physician OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M294%N/AN/A
#2
$3.2M160%N/AN/A
#3
$83.2M4147%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$10.9M546%N/AN/A
#7
$6.8M34-6%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$49.4M2466%N/AN/A
Add Company

What Is Velocity Clinical Research?

Velocity Clinical Research is a site organization with multiple locations. We control our own data, patient care, and outcomes, from study feasibility to database lock. We have one goal: to deliver high-quality clinical trial data from as many patients as possible, as quickly as possible ᅢᄁ¬ツᆲ¬タワ providing exemplary patient care at every step. Who We Are Velocity Clinical Research is 100% committed to the successful delivery of clinical studiesᅢᄁ¬ツᆲ¬タンhelping our clients maintain the highest standards of care while bringing new medications directly to the patients who need them, as quickly and efficiently as possible. Our sites have over 20 years of experience and more than 1700 completed studies in a wide range of therapeutic areas. Support for Sponsors All site staff, including Medical Directors, are employees of Velocity Clinical Research. We simplify sponsor engagement by providing a central contact for feasibility, contracting, patient recruitment, study management, billing, and payment, whether a sponsor uses one of our sites or all of them. We are committed to rapid responsiveness from contracting to close-out. Our processes are designed to deliver patients and data as quickly as possible without sacrificing exemplary data quality or patient care. We work hard to deliver outstanding patient care. It is crucial for our patients and their families and contributes to the well-being of the communities we serve. Committed to Patients We hire staff who are dedicated to providing excellent patient care. The best clinical researcher is not effective if they do not put patient needs and concerns first. We prioritize positive patient outcomes. Making patients feel comfortable and well-cared for is a predictor of a well-executed study with high quality data. The highest compliment a patient can pay us is to enroll in another study or refer their friends and relatives. That is our goal.

keywords:N/A

N/A

Total Funding

357

Number of Employees

$71.8M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Velocity Clinical Research News

2022-04-17 - Ripple Science and Velocity Research Sign Pilot Agreement for Ripple Recruit Software

Velocity Clinical Research's CEO, Dr Paul Evans, said: “Velocity's mission is to speed up clinical research so that life-saving drugs can get to...

2022-03-30 - FDA approves 2 mg semaglutide to lower HbA1c in type 2 ...

... MD, FACE, medical director of Velocity Clinical Research in Los Angeles and principal investigator of the SUSTAIN FORTE clinical trial,...

2021-08-12 - Velocity Clinical Research strengthens management team amid European expansion USA - English France - Français Polska - Polski España - español Deutschland - Deutsch USA - English

DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion. Pharmaceutical industry heavyweights have joined th ...

2021-04-08 - Velocity Clinical Research acquired by GHO signalling evolution of clinical trial site industry

DURHAM, N.C., April 8, 2021 /PRNewswire/ -- Leading integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has entered into an agreement with Global Healthcare Opportunities, or GHO Capital ("GHO"), the European specialist investor in healthcar ...

2021-03-17 - Velocity Clinical Research acquires two new sites, signaling commitment to diversifying patient recruitment

Acquisition of Downtown Women's Health Facility comes amid women's history month Velocity moves into renal and hepatic research with Riverside Clinical Research acquisition DURHAM, North Carolina, March 17, 2021 /PRNewswire/ -- Leading US integrated site company, Velocity Clinical Research, t ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$81.5M36218%N/A
#2
$81.9M36421%N/A
#3
$75M367N/AN/A
#4
$96.3M36732%N/A
#5
$113M3729%N/A